Cargando…
Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond
It remains a challenge for the effective treatment of neuroinflammatory disease, including multiple sclerosis (MS), stroke, epilepsy, and Alzheimer’s and Parkinson’s disease. The voltage-gated potassium Kv1.3 channel is of interest, which is considered as a novel therapeutic target for treating neur...
Autores principales: | Wang, Xiaoli, Li, Guoyi, Guo, Jingkang, Zhang, Zhiping, Zhang, Shuzhang, Zhu, Yudan, Cheng, Jiwei, Yu, Lu, Ji, Yonghua, Tao, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971160/ https://www.ncbi.nlm.nih.gov/pubmed/31992966 http://dx.doi.org/10.3389/fnins.2019.01393 |
Ejemplares similares
-
Corrigendum: Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond
por: Wang, Xiaoli, et al.
Publicado: (2020) -
Glycosylation of β1 subunit plays a pivotal role in the toxin sensitivity and activation of BK channels
por: Wang, Xiaoli, et al.
Publicado: (2021) -
The Mitochondrial Routing of the Kv1.3 Channel
por: Capera, Jesusa, et al.
Publicado: (2022) -
The potassium channel Kv1.3 as a therapeutic target for immunocytoprotection after reperfusion
por: Chen, Yi‐Je, et al.
Publicado: (2021) -
Anticonvulsant Effects of Dingxian Pill in Pentylenetetrazol-Kindled Rats
por: Zhu, Yudan, et al.
Publicado: (2019)